Showing results (101-110 of 142) with videos related to
Sort By:
Pageof 15
American Journal of Clinical Dermatology|May 22, 2019
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary HyperhidrosisDee Anna Glaser, Adelaide A Hebert, Alexander Nast, et al.Pediatric Dermatology|January 10, 2018
Pediatric psoriasis: Evolving perspectivesLawrence F Eichenfield, Amy S Paller, Wynnis L Tom, et al.Current Medical Research and Opinion|July 10, 2018
Patient impact and economic burden of mild-to-moderate atopic dermatitisAdelaide A Hebert, Georg Stingl, LoAn K Ho, et al.Journal of Drugs in Dermatology : JDD|August 5, 2026
Molluscum Contagiosum in the Pediatric Population: Expert Consensus Guidance on Prevention and TreatmentNanette B Silverberg, Latanya Benjamin, Mercedes E Gonzalez, et al.Journal of Drugs in Dermatology : JDD|August 5, 2026
Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% Gel for Acne: Pooled Analysis by Age and SexJulie C Harper, Heather C Woolery-Lloyd, Linda Stein Gold, et al.Dermatology and Therapy|January 8, 2025
Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and ChildrenEric L Simpson, Adelaide A Hebert, John Browning, et al.Pediatric Dermatology|December 21, 2021
Higher rates of skin clearance and efficacy in challenging body areas are associated with better health-related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasisAdelaide A Hebert, Margaret A Bobonich, Claudia Rodriguez Capriles, et al.JAMA Dermatology|July 17, 2014
Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus StatementsJoyce M C Teng, Edward W Cowen, Mari Wataya-Kaneda, et al.Journal of Drugs in Dermatology : JDD|March 5, 2024
Early and Sustained Acne Lesion Reductions With Fixed-Dose Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% GelJulie C Harper, Leon H Kircik, Michael Gold, et al.The Journal of Dermatological Treatment|August 30, 2008
Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adultsWilliam Abramovits, Adelaide A Hebert, Mark Boguniewicz, et al.Pageof 15